Population Pharmacokinetics (PopPK) of Quizartinib and Its Active Metabolite AC886 in Patients (Pts) With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) ACoP13 (Nov 2022), Poster M-027 Vaddady P, Smania G, Glatard A, Nakayama S, Inoue H, Kurumaddali A, Abutarif M, Sheng M. ConferenceMIDDOncologyPharmacometricsRegulatory interactions Pharmetheus Affiliates Senior Consultant & Team Leader Giovanni Smania See bio Senior Consultant Anaïs Glatard See bio
